Financials

Discussions Seasonals

APUS fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Apimeds Pharmaceuticals US, Inc.

Total assets of APUS for Q4 24 is 13.06 k USD, 64.62% less than the previous Q3 24. And total liabilities increased by 26.56% in Q4 24 to 1.37 M USD.

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—